PS178. Expanded Use of the Hemodialysis Reliable Outflow (HeRO) Vascular Access Device for Permanent Dialysis Access in Patients with Total Central Venous Occlusion  by O'Brien, Patrick J. et al.
c
b
p
t
t
g
c
a
r
t
H
e
s
i
o
A
C
s
m
P
F
U
K
o
t
a
p
f
c
g
r
c
2
m
p
i
o
a
m
d
s
(
o
t
a
s
u
t
JOURNAL OF VASCULAR SURGERY
June Supplement 201176S Abstractswere already on dialysis. Median operative time was 100
minutes. Fifty-six percent patients received general anes-
thesia. Forty-one (2.0%) patients developed a wound infec-
tion, 51 (2.5%) patients developedmechanical failure of the
fistula requiring intervention, and 109 (5.4%) patients had
to return to the operating room. Thirty-day morbidity and
mortality rates were 11.7% and 1.1%, respectively. On
multivariate analysis, three preoperative predictors of mor-
tality were identified: age, dyspnea, and admission from
chronic care facility.
Conclusions: Morbidity and mortality rates following
AVF formation are low, making them relatively safe proce-
dures. We present outcomes from this large database to
define an average for the surgeon to compare their experi-
ence. These data will be used by third party interests, and
surgeons must understand it to place their outcomes into
the national norm.
Author Disclosures: M. Balters: Nothing to disclose; R.
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Lynch: Nothing to disclose; J. N. MacTaggart: Nothing
to disclose; B. Natarajan: Nothing to disclose; I. I. Pipi-
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Expanded Use of the Hemodialysis Reliable Outflow
(HeRO) Vascular Access Device for Permanent Dialysis
Access in Patients with Total Central Venous Occlusion
Patrick J. O’Brien1, Charles Y. Kim2, Shawn M. Gage1,
Jeffrey H. Lawson1. 1Section of Vascular Surgery, Duke
University Medical Center, Durham, NC; 2Division of
Vascular & Interventional Radiology, Duke University
Medical Center, Durham, NC
Objectives: Central venous occlusion often results in
reliance on catheter-based dialysis access, which is a well-
established source of significant morbidity and mortality.
We retrospectively reviewed our experience with recanali-
zation of totally occluded central venous segments and
subsequent implantation of the HeRO vascular access de-
vice to provide permanent access in this catheter-dependent
population.
Methods: From September 2008 to July 2010, eight
catheter-dependent patients with total central venous occlu-
sion were identified. A catheter and guidewire system, using
both an upper extremity and femoral approach, was used to
traverse the central occlusion. Angioplasty was performed to
secure a tunneled catheter across the occluded segment for
future guidewire access andHeRO implantation.A temporary
tunneled catheter was used for hemodialysis access until the
HeRO graft was suitable for cannulation.
Results: HeRO implantation was successfully performed
in all eight patients. The mean age and length of time on
dialysis was 53.6 and 6.9 years, respectively. The recanalized uentral venous segment was the superior vena cava (n4),
rachiocephalic vein (n3), or subclavian vein (n1). One
atient died on postoperative day 11 of unrelated gastrointes-
inal bleeding. Mean follow-up for the remaining seven pa-
ients was 12.9 months (range 5-23 months). On average,
rafts were successfully accessed in 22.6 days, with patients
atheter-free at 29 days. Primary and secondary patency rates
t 6 months were 51% and 100%, respectively. One graft
equired revision secondary to local infection.
Conclusions: Recanalization of totally occluded cen-
ral venous segments followed by implantation of the
eRO device for permanent dialysis access is feasible, with
xcellent short-term patency in our current series. This
trategy may reduce the morbidity associated with chronic
ndwelling hemodialysis catheters, and extend anatomic
ptions previously abandoned in high-risk patients.
uthor Disclosures: S. M. Gage: Nothing to disclose;
. Y. Kim: Nothing to disclose; J. H. Lawson: Hemo-
phere, Inc.,Consulting fees or other remuneration (pay-
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actors Influencing Catheter Use for Hemodialysis in a
niversity-Associated Dialysis Center
aren Woo, Baron Thompson, Vincent Rowe. University
f Southern California, Los Angeles, CA
Objectives: To determine factors that influence use of
unneled catheters for hemodialysis in a single, university-
ssociated dialysis center.
Methods: A retrospective review was performed of
atients from a single university associated dialysis center
rom 2004-2009. Length of catheter use and number of
atheter placements per patient were analyzed. Demo-
raphics, co-morbidities and insurance status were also
ecorded.
Results: 403 patients were identified who had used a
atheter for hemodialysis on at least one occasion.
17 (54%) were males and 186 (46%) were females. The
ajority of the patients were Hispanic (76%). 78% of the
atients had diabetes. 168 (42%) of the patients had Med-
caid type insurance and 186 (46%) had Medicare. The
verall mean number of days using a catheter for hemodi-
lysis was 415. The overall mean number of catheter place-
ents was 2.1. Females had significantly more catheter use
ays than males (486 vs 354, P .04). Females also had
ignificantly more catheter placement events than males
2.3 vs 1.9, P 0.02). Insurance status did not affect number
f days using a catheter or number of catheter placements.
Conclusions: Catheter use for hemodialysis continues
o be significant in this predominantly Hispanic population
t a university-associated dialysis center. Female sex is a
ignificant predictor of catheter use. The reasons for this are
nclear. Further study is needed to determine the causes of
his discrepancy and identify strategies to decrease catheter
se in the hemodialysis population.
